To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
9,534 Current news from the industry biotechnologyrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
License to accelerate research, enable testing and development of new drugs
Merck announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an international biotechnology company headquartered in Hamburg, Germany, will use Merck’s CRISPR genome-editing technology to create edited cell lines ...
Technology may help guide treatment of Alzheimer's, Parkinson's diseases
A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer's and Parkinson's diseases and other neurological disorders. The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors ...
Lonza announced that Marc Funk, CEO, will leave the Company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on the additional responsibility of Chief Executive Officer on an ad interim basis until a permanent successor is found. Marc will stay ...
evitria AG announces the opening of its new head office in Denmark to better serve the growing demand from Scandinavian enterprises. evitria's Nordic office will be headed by Simon Asbjørn Larsen, PhD as Director, Client Relations. Dr. Larsen specialized in recombinant antibody technology during ...
Quality of induced pluripotent stem cells is dramatically enhanced by omitting what was thought to be the most crucial reprogramming factor. Scientists at the Max Planck Institute for Molecular Biomedicine in Münster showed that Oct4, a factor most commonly used for reprogramming, is detrimental ...
Investment to support development of human-compatible xeno organs to address the global organ shortage crisis
eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of effective human-compatible organs to address the global organ shortage, successfully completed a USD 100 million Series B financing. The financing was led by Fresenius Medical Care Ventures ...
Science Barometer Switzerland
The Swiss population’s trust in science and research is high to very high. As the Science Barometer Switzerland 2019 study shows, people in Switzerland have a positive attitude towards science and are keen to receive information about research, with climate and energy considered the most ...
New findings are expected to help protect the hydrogen-producing enzymes from harmful oxygen – which is interesting for biotechnological applications. Certain enzymes, such as hydrogen-producing hydrogenases, are unstable in the presence of oxygen. Researchers at Ruhr-Universität Bochum (RUB) ...
EMBL scientists have developed a new variant of the Sleeping Beauty transposase. It has dramatically improved biochemical features, including enhanced stability and intrinsic cell penetrating properties. This transposase can be used for genome engineering of stem cells and therapeutic T cells. As ...
Dental Stem Cells Can Generate Milk-Producing Cells
Stem cells of the teeth can contribute to the regeneration of non-dental organs, namely mammary glands. According to a new study from researchers at the University of Zurich, dental epithelial stem cells from mice can generate mammary ducts and even milk-producing cells when transplanted into ...